Mometahexal Heuschnupfenspray (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometahexal Heuschnupfenspray, is a corticosteroid presented as a nasal spray for nasal use. It treats allergic rhinitis and seasonal nasal allergy in adults and children by reducing nasal mucosal inflammation, thereby relieving congestion, itching, sneezing and rhinorrhea.

GNH USA supplies Mometahexal Heuschnupfenspray as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance, regulatory compliance and reliable global logistics for prescription medicines and timely delivery to meet patient needs.

Mometahexal Heuschnupfenspray, a nasal corticosteroid, is indicated for inflammatory nasal conditions that cause allergic symptoms. - Allergic rhinitis: reduces nasal congestion, itching, sneezing and rhinorrhea, improving daily comfort. - Seasonal nasal allergy: alleviates inflammation caused by pollen or mold exposure, decreasing symptom severity. - Hay fever: provides rapid relief of nasal obstruction and irritation associated with outdoor allergens. - Nasal irritation from environmental irritants: helps control symptoms triggered by dust or strong odors.

Adverse reactions may occur with intranasal corticosteroids, including Mometahexal Heuschnupfenspray.

Common Side Effects: - Nasal irritation or burning sensation - Headache - Epistaxis (nosebleed) - Throat irritation or dryness - Altered taste or unpleasant taste - Cough

Serious or Rare Side Effects: - Nasal septal perforation - Severe or recurrent epistaxis - Vision changes such as cataracts or glaucoma - Systemic glucocorticoid effects (e.g., adrenal suppression) - Opportunistic fungal infection of the nasal passages

Before using Mometahexal Heuschnupfenspray, consider the following precautions. - Assess for active nasal infection: avoid use until infection resolves. - Avoid in children under 2 years of age unless specifically prescribed. - Monitor for signs of systemic glucocorticoid exposure, especially with prolonged use. - Do not combine with other intranasal corticosteroids without medical guidance. - Instruct patients on proper spray technique to minimize local irritation. - Store at room temperature: keep in the original container, protect from moisture and heat.

Mometasone furoate may interact with other medicines; review the following.

Major Interactions (Avoid): - Systemic corticosteroids: additive glucocorticoid effects may increase risk of systemic side effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir): may raise local drug exposure. - Live vaccines: immunosuppression could reduce vaccine efficacy.

Moderate Interactions (Monitor Closely): - Antifungal agents metabolized by CYP3A4: may modestly increase mometasone levels. - NSAIDs: concurrent use can increase the likelihood of nasal bleeding. - Antihistamines: generally safe but monitor for combined drying effects on nasal mucosa.